HIMS Hims Hers Health Inc
Company Analysis
Latest News
Barclays Bets Big on Hims & Hers' Weight-Loss Comeback — But Can the Margins Keep Up With the Momentum?
Shares surged as Barclays handed Hims & Hers Health its most aggressive Wall Street endorsement in months, lifting its price target 34% — from $29 to $39 — and...
🟢 Hims Hers Health Inc is trading 6.9% up today after Barclays raised its price target on strong GLP-1 growth momentum
Hims Hers Health Inc is trading 6.9% up at $34.09 following a bullish note from Barclays highlighting significant reacceleration in the company’s weight loss...
Hims & Hers Eyes 34% Upside, Driven by GLP-1 Growth
Barclays raised its price target for Hims & Hers Health (NYSE: HIMS) to $39 from $29. This adjustment represents a potential upside of more than 34%. The bank...
🟢 Hims Hers Health Inc extends move to 5.1% up
HIMS is trading at $33.08, up 5.1% versus the comparison close of $31.47 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Hims Hers Health Inc is trading 4.1% up today as weight-loss growth expectations fuel multi-day rally
Hims Hers Health Inc is trading 4.1% up now at $32.75 as investors extend a sharp multi-day rally following bullish growth expectations in new weight-loss...
Hims & Hers jumps 12%, eyeing $19 billion peptide market expansion
Hims & Hers Health (HIMS) shares surged over 12% on Monday. This rally marks the stock's strongest single-day performance in two months. Investor optimism...
🟢 Hims Hers Health Inc extends move to 5.3% up
HIMS is trading at $31.76, up 5.3% versus the comparison close of $30.17 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Hims Hers Health Inc is trading 4.5% up today as shareholder support reinforces GLP-1 strategy confidence
Hims Hers Health Inc is trading at $31.52 (4.5% up) as investors react to confirmed shareholder support for the company's GLP-1 strategy and long-term growth...
Hims & Hers Shareholders Elect Nine Directors and Approve All Proposals at Annual Meeting
Hims & Hers Health, Inc. announced the voting results from its 2026 Annual Meeting of Stockholders held on June 11, 2026. All three proposals presented to...
🟢 Hims Hers Health Inc makes sharp 10.2% jump
HIMS is trading at $29.56, up 10.2% versus the comparison close of $26.82 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Hims Hers Health Inc is trading 7.1% up today amid a broader risk-on rally in growth stocks
Hims Hers Health Inc is trading 7.09% up at $28.72 as growth stocks advance during a broader risk-on session for U.S. equities. • The stock saw a sharp...
🟢 Hims Hers Health Inc is trading 4.1% up today tracking a broader market rally
Hims Hers Health Inc is trading 4.1% up at $28.91 as the stock tracks a broader risk-on session with major U.S. indices rising over 1%. • The advance follows...
🟢 Hims Hers Health Inc is trading 5.7% up today after cutting GLP-1 entry pricing to $39
Hims Hers Health Inc is trading 5.7% up at $28.73 after announcing a lower-cost GLP-1 weight-loss membership. • The company reduced the first-month price for...
Hims & Hers slashes GLP-1 entry price to $39, removing upfront commitments
Hims & Hers Health Inc. introduced a more accessible weight loss membership model. The company reduced the initial cost for its GLP-1 programs to $39 for the...
🟢 Hims Hers Health Inc is trading 4.1% up today in a rebound following its post-acquisition pullback
Hims Hers Health Inc is trading at $27.27, up 4.1%, as the stock recovers from a 6.5% drop on June 5 following a volatile rally linked to its GLP-1...
🔴 Hims Hers Health Inc is trading 5.7% down today in a pullback after recent GLP-1 and Eucalyptus-driven gains
Hims Hers Health Inc is trading 5.7% down at $26.42 as the stock undergoes a pullback following a sharp multi-day rally driven by its $1.15 billion Eucalyptus...
🔴 Hims Hers Health Inc is trading 5.5% down today after a sharp multi-day rebound tied to its Eucalyptus acquisition and GLP-1 strategy
Hims Hers Health Inc is trading 5.5% down today at $26.48 as the stock pulls back following a sharp multi-day rebound tied to the reassessment of its $1.15...
🟢 Hims Hers Health Inc is trading 5.6% up today as shares extend a rebound from Eucalyptus acquisition and dilution concerns
Hims Hers Health Inc is trading 5.6% up at $29.05, extending a sharp multi-day rebound as investors reassess the impact of its $1.15 billion Eucalyptus...
🔴 Hims & Hers Health Inc. falls 4.5% as investors weigh Eucalyptus acquisition and potential dilution
Hims & Hers Health Inc. is trading 4.5% down at $26.27 as investors react to the company's recently completed acquisition of Australian telehealth platform...
Hims & Hers Completes Acquisition of Eucalyptus, Expanding Global Consumer Health Platform
Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, a digital health company, significantly expanding its international footprint and...